Latest Whitepapers
Whitepaper
Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.
Whitepaper
Transitioning from Using RUO to CGMP Chemicals for Clinical Trials
This whitepaper explores how transitioning from RUO to cGMP chemicals can mitigate risks, streamline processes and maintain regulatory compliance, ultimately accelerating your journey from lab to clinic.
Whitepaper
How To Accelerate Vaccine Production – And Avoid Speed Bumps
This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.
Whitepaper
Gene Therapy: A New Frontier in Disease-Modifying Therapies
This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.
Whitepaper
Organ-on-Chips Revolutionize Drug Safety Testing
This whitepaper explores the latest advancements in OOC platforms that can help to efficiently simulate drug toxicity responses.
Whitepaper
Advances in Cell Therapy
This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Whitepaper
Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis
Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.
Whitepaper
Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing
This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.
Whitepaper
Improving Cancer Patient Care With Professor Mark Lawler
In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
Whitepaper
Cell Culture – Good Practice and Advanced Methods
This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.
Advertisement